ArticleFrontiers in microbiology2021
Isolation and Characterization of
Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 42 citations in OpenAlex.
- New biopreparation against Neofabraea, the causal agent of Bull's Eye Rot - development and influence on the apple's microbial community at the practical scale.Pest management science · 2026Article
- Review
- Isolation and characterization of new antagonistic bacteria P10-7 and evaluation of its biocontrol potential against tomato gray mold.Frontiers in microbiology · 2025Article
- Article
- Whole genome sequence of seaweed endophyte Bacillus halotolerans strain AUPP for antagonistic activity against Fusarium incarnatum causing chilli fruit rot.Scientific reports · 2024Article
- Characterization and Biocontrol Efficacy of Bacillus velezensis GYUN-1190 against Apple Bitter Rot.The plant pathology journal · 2024Article
- Enhanced Antifungal Efficacy of Validamycin A Co-Administered withPlants (Basel, Switzerland) · 2024Article
- Biocontrol of Peach Gummosis byJournal of microbiology and biotechnology · 2024Article
- Article
- Cervicovaginal Bacillus velezensis Isolate: A Potential Probiotic and an Antagonist Against Candida and Staphylococcus.Current microbiology · 2023Article
- Biocontrol ability ofFrontiers in microbiology · 2023Article
- Biocontrol activity ofFrontiers in microbiology · 2022Article
- Genomics assisted functional characterization ofFrontiers in microbiology · 2022Article
- Biocontrol activity and action mechanism ofFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.